The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'connor Donal since 2015.
This trader's CIK number is 1625377.
At the time of last reporting, O'connor Donal was the Director of Perrigo Co Plc. (stock ticker symbol PRGO).
Also see all insider trading activities at Perrigo Co Plc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PRGO | 0 | $0 | 0 | $0 | 9,904 | $257,603 |
2024 | PRGO | 0 | $0 | 0 | $0 | 8,764 | $264,848 |
2023 | PRGO | 0 | $0 | 0 | $0 | 7,778 | $255,585 |
2022 | PRGO | 0 | $0 | 0 | $0 | 6,599 | $254,523 |
2021 | PRGO | 0 | $0 | 0 | $0 | 5,804 | $249,339 |
2020 | PRGO | 0 | $0 | 0 | $0 | 6,054 | $319,409 |
2019 | PRGO | 0 | $0 | 0 | $0 | 3,971 | $196,763 |
2018 | PRGO | 0 | $0 | 0 | $0 | 4,265 | $312,283 |
2017 | PRGO | 0 | $0 | 0 | $0 | 3,263 | $237,709 |
2015 | PRGO | 0 | $0 | 0 | $0 | 1,929 | $283,370 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | TBPH | 0 | $0 | 4,000 | $81,834 | 0 | $0 |
2. Theravance Biopharma, Inc. (TBPH)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-14 | PRGO | Option Ex | 9,904 | 26.01 | 257,603 |
2024-05-15 | PRGO | Option Ex | 8,764 | 30.22 | 264,848 |
2023-05-17 | PRGO | Option Ex | 7,778 | 32.86 | 255,585 |
2022-05-17 | PRGO | Option Ex | 6,599 | 38.57 | 254,523 |
2021-05-07 | PRGO | Option Ex | 5,804 | 42.96 | 249,339 |
2020-05-15 | PRGO | Option Ex | 6,054 | 52.76 | 319,409 |
2019-05-15 | PRGO | Option Ex | 3,971 | 49.55 | 196,763 |
2018-06-06 | PRGO | Option Ex | 4,265 | 73.22 | 312,283 |
2017-05-31 | PRGO | Option Ex | 3,263 | 72.85 | 237,709 |
2015-11-13 | PRGO | Option Ex | 1,929 | 146.90 | 283,370 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-05-17 | TBPH | Sale | 2,673 | 20.19 | 53,967 |
2019-05-16 | TBPH | Sale | 1,327 | 21.00 | 27,867 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'connor Donal (Director of Perrigo Co Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.